Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
bioAffinity Technologies, Inc. ( (BIAF) ) has issued an announcement.
bioAffinity Technologies, Inc. has announced plans for its 2025 Annual Meeting of Stockholders, which will take place on July 25, 2025. The company has set the record date for determining stockholders entitled to vote at the meeting as May 29, 2025. Due to the meeting being scheduled more than 30 days after the previous year’s meeting, revised deadlines for stockholder proposals have been provided. Proposals under Rule 14a-8 must be submitted by May 26, 2025, while notices for director nominations must comply with Rule 14a-19 by May 29, 2025.
The most recent analyst rating on (BIAF) stock is a Buy with a $6.00 price target. To see the full list of analyst forecasts on bioAffinity Technologies, Inc. stock, see the BIAF Stock Forecast page.
Spark’s Take on BIAF Stock
According to Spark, TipRanks’ AI Analyst, BIAF is a Neutral.
bioAffinity Technologies, Inc.’s stock is affected by several significant challenges. While revenue growth is a positive indicator, the company struggles with profitability, high leverage, and negative cash flows, leading to a fragile financial position. Technical analysis suggests a bearish trend, with potential for a short-term rebound due to oversold conditions. The negative P/E ratio and absence of dividends make the stock unappealing from a valuation perspective. These factors result in a low overall stock score, reflecting the substantial risks associated with this investment.
To see Spark’s full report on BIAF stock, click here.
More about bioAffinity Technologies, Inc.
Average Trading Volume: 10,097,729
Technical Sentiment Signal: Sell
Current Market Cap: $5.77M
See more data about BIAF stock on TipRanks’ Stock Analysis page.